Pentoxifylline inhibits the fibrogenic activity of pleural effusions and transforming growth factor-β
Physiopathology of organ fibrosis is far from being completely understood, and the efficacy of the available therapeutic strategies is disappointing. We chose pleural disease for further studies and addressed the questions of which cytokines are relevant in pleural fibrosis and which drugs might int...
Main Authors: | P. Entzian, M. Schlaak, U. Seitzer, Y. Acil, M. Ernst, P. Zabel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1997-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629359791811 |
Similar Items
-
Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
by: Xiao Liu, et al.
Published: (2019-05-01) -
Pleural manometry in pleural effusion
by: Mohamed Galal, et al.
Published: (2016-04-01) -
Pleural effusion
by: Mariia A. Karnaushkina, et al.
Published: (2019-03-01) -
Pancreatic pleural effusion masquerading as right sided tubercular pleural effusion
by: Gopal Chawla, et al.
Published: (2019-09-01) -
Tuberculose pleural Tuberculous pleural effusions
by: Márcia Seiscento, et al.
Published: (2006-08-01)